ConductScience.org, home

Paper3034331

Recent studies of DNA topoisomerases.

Wang JC. Biochim Biophys Acta, 1987. Cited by 349 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Recent studies of DNA topoisomerases. Papers, record 3034331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3034331

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent studies of DNA topoisomerases.
PubMed
Journal
Biochim Biophys Acta
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
349
iCite
Relative citation ratio, by iCite
9.17
iCite
Revised in PubMed
2024-01-09
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang JCJ C

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA Topoisomerases, Type IMajor topic
DNA Topoisomerases, Type IIMajor topic
Animals
DNA Replication
DNA, Superhelical
Genes

Source PubMed

Cited by71

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 349 citations.

PMIDTitleJournalYearIn PapersSource
38,505,520Insights into the cell fate decision-making processes from chromosome structural reorganizations.Biophys Rev (Melville)2022https://conductscience.org/library/papers/38505520PubMed
34,752,443Deciphering the molecular mechanism of the cancer formation by chromosome structural dynamics.PLoS Comput Biol2021https://conductscience.org/library/papers/34752443PubMed
33,101,859Microscopic Chromosomal Structural and Dynamical Origin of Cell Differentiation and Reprogramming.Adv Sci (Weinh)2020https://conductscience.org/library/papers/33101859PubMed
27,224,483Simulation of DNA Supercoil Relaxation.Biophys J2016https://conductscience.org/library/papers/27224483PubMed
20,046,765Antifungals: need to search for a new molecular target.Indian J Pharm Sci2008https://conductscience.org/library/papers/20046765PubMed
16,669,064Cloning and Characterization of an Arabidopsis thaliana Topoisomerase I Gene.Plant Physiol1992https://conductscience.org/library/papers/16669064PubMed
14,577,595Membrane-bound alkaline phosphatase gene induces antitumor effect by G2/M arrest in etoposide phosphate-treated cancer cells.Mol Cell Biochem2003https://conductscience.org/library/papers/14577595PubMed
9,678,572Cloning, expression and characterization of a gene which encodes a topoisomerase I with positive supercoiling activity in pea.Plant Mol Biol1998https://conductscience.org/library/papers/9678572PubMed
9,049,244Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.J Cell Biol1997https://conductscience.org/library/papers/9049244PubMed
8,943,335Targeted disruption of the mouse topoisomerase I gene by camptothecin selection.Mol Cell Biol1996https://conductscience.org/library/papers/8943335PubMed
8,843,298
Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.
Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8843298PubMed
8,452,351Activity of quinolones in the Ames Salmonella TA102 mutagenicity test and other bacterial genotoxicity assays.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8452351PubMed
8,394,365Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor.J Cancer Res Clin Oncol1993https://conductscience.org/library/papers/8394365PubMed
8,389,456Reverse gyrase: a helicase-like domain and a type I topoisomerase in the same polypeptide.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8389456PubMed
8,387,398DNA topoisomerase I and II in cancer chemotherapy: update and perspectives.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8387398PubMed
8,381,639Coumermycin A1 inhibits growth and induces relaxation of supercoiled plasmids in Borrelia burgdorferi, the Lyme disease agent.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8381639PubMed
8,324,865The effect of NC-190, a novel antitumor compound, on the cell-cycle progression of HeLa S3 cells.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8324865PubMed
8,289,331Association between the p170 form of human topoisomerase II and progeny viral DNA in cells infected with herpes simplex virus type 1.J Virol1994https://conductscience.org/library/papers/8289331PubMed
8,258,194Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8258194PubMed
8,255,771Induction of cleavage in topoisomerase I c-DNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin.Nucleic Acids Res1993https://conductscience.org/library/papers/8255771PubMed

See all 71 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3034331

GET https://conductscience.org/api/papers/v1/3034331/cited_by?page=2